Evidence map›Paper›PMID 38163325›Full record

ArticlePLoS biology2024

Reduced serotonergic transmission alters sensitivity to cost and reward via 5-HT1A and 5-HT1B receptors in monkeys.

Yukiko Hori, Koki Mimura, Yuji Nagai, Yuki Hori, Katsushi Kumata, Ming-Rong Zhang, Tetsuya Suhara, Makoto Higuchi, Takafumi Minamimoto

Open access · goldAbstract read
In one paragraph

Article in PLoS biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Effects of a 5-HTScientific reports · 2024
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Yukiko HoriDepartment of Functional Brain Imaging, National Institutes for Quantum Science and Technology, Chiba, Japan.
Koki MimuraDepartment of Functional Brain Imaging, National Institutes for Quantum Science and Technology, Chiba, Japan.
Yuji NagaiDepartment of Functional Brain Imaging, National Institutes for Quantum Science and Technology, Chiba, Japan.
Yuki HoriDepartment of Functional Brain Imaging, National Institutes for Quantum Science and Technology, Chiba, Japan.
Katsushi KumataDepartment of Advanced Nuclear Medicine Sciences, National Institutes for Quantum Science and Technology, Chiba, Japan.
Ming-Rong ZhangDepartment of Advanced Nuclear Medicine Sciences, National Institutes for Quantum Science and Technology, Chiba, Japan.
Tetsuya SuharaDepartment of Functional Brain Imaging, National Institutes for Quantum Science and Technology, Chiba, Japan.
Makoto HiguchiDepartment of Functional Brain Imaging, National Institutes for Quantum Science and Technology, Chiba, Japan.
Takafumi MinamimotoDepartment of Functional Brain Imaging, National Institutes for Quantum Science and Technology, Chiba, Japan.ORCID 0000-0003-4305-0174
National Institutes for Quantum Science and Technology · JP

Funding

Japan Science and Technology Agency (JST)Japan Society for the Promotion of Science (JSPS)Moonshot Research & Development Program (Millennia Program)
6 · The paper itself

Abstract

Serotonin (5-HT) deficiency is a core biological pathology underlying depression and other psychiatric disorders whose key symptoms include decreased motivation. However, the exact role of 5-HT in motivation remains controversial and elusive. Here, we pharmacologically manipulated the 5-HT system in macaque monkeys and quantified the effects on motivation for goal-directed actions in terms of incentives and costs. Reversible inhibition of 5-HT synthesis increased errors and reaction times on goal-directed tasks, indicating reduced motivation. Analysis found incentive-dependent and cost-dependent components of this reduction. To identify the receptor subtypes that mediate cost and incentive, we systemically administered antagonists specific to 4 major 5-HT receptor subtypes: 5-HT1A, 5-HT1B, 5-HT2A, and 5-HT4. Positron emission tomography (PET) visualized the unique distribution of each subtype in limbic brain regions and determined the systemic dosage for antagonists that would achieve approximately 30% occupancy. Only blockade of 5-HT1A decreased motivation through changes in both expected cost and incentive; sensitivity to future workload and time delay to reward increased (cost) and reward value decreased (incentive). Blocking the 5-HT1B receptor also reduced motivation through decreased incentive, although it did not affect expected cost. These results suggest that 5-HT deficiency disrupts 2 processes, the subjective valuation of costs and rewards, via 5-HT1A and 5-HT1B receptors, thus leading to reduced motivation.

Indexed as

SerotoninSerotonin AntagonistsAnimalsBrainCarrier ProteinsMacacaReceptor, Serotonin, 5-HT1BCarrier ProteinsReceptor, Serotonin, 5-HT1BSerotoninSerotonin Antagonists

Identifiers

PMID38163325
PMCPMC10758260
OpenAlexW4390479336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.